ZeroStack Corp.
ZeroStack Corp. is a U.S.-listed company with operations spanning pharmaceutical distribution, cannabis-related consumer products, and a treasury strategy centered on digital assets tied to AI infrastructure. Its operating businesses include the German-based Phatebo wholesale pharmaceutical distributor, the JustCBD consumer brand, cannabis accessories and technology, and other international distribution activities through subsidiaries in the United States, Germany, and Australia.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2021–2025
Liiketoiminta
Osuus liikevaihdostaDistribution of pharmaceutical goods and medical products through Phatebo and related channels.
Branded hemp- and CBD-based consumer packaged goods sold through retail and specialty channels.
Consumer accessories and technology products sold under the Vessel brand and related offerings.
Distribution of cannabis-infused drink products through United Beverage Distribution.
Strategic ownership and treasury exposure to 0G Tokens and related AI ecosystem assets.
Asiakkaat
ZeroStack sells to pharmaceutical wholesalers, healthcare-related buyers, and international distribution partners through its commercial and wholesale business. Its branded consumer products are purchased by specialty retail channels such as smoke and vape shops, clinics, spas, pet stores, and other non-traditional retail outlets, while cannabis-related products also reach end consumers through retail and online channels. The pharmaceutical side serves buyers that need regulated supply, product breadth, and cross-border sourcing capabilities.
Buy imported and exported pharmaceutical goods for regulated resale and healthcare supply.
Purchase CBD and hemp-derived products for resale in smoke shops, vape shops, clinics, spas, and pet stores.
Buy branded CBD, accessories, and related wellness products through e-commerce and direct channels.
Buy cannabis-infused drinks and related products for regional distribution and retail placement.
Indirect exposure through the 0G treasury strategy and related ecosystem investments.
Strategia
ZeroStack’s stated direction combines an AI-focused treasury strategy with operating businesses that generate cash flow from pharmaceutical distribution and branded consumer products. The company is also pursuing broader geographic reach, strategic partnerships, and acquisitions to expand its footprint and diversify sources of cash flow. Its operating model links regulated distribution businesses with a digital-asset allocation strategy centered on 0G Tokens.
The company wants to create value through strategic ownership of AI-linked digital assets.
Pharmaceutical distribution and branded products provide operating revenue outside the treasury strategy.
Broader market access reduces dependence on any single country or regulatory regime.
The company has indicated that inorganic growth can supplement organic expansion.
Maantiede
Q1/2026ZeroStack operates through subsidiaries in the United States, Germany, and Australia, with principal pharmaceutical operations in Germany. Management also describes pharmaceutical distribution across 28 countries globally, primarily in Europe, with additional sales into Asia, Latin America, and North America. Geography matters because the company’s operating model depends on local regulatory approvals, cross-border logistics, and differing legal treatment of cannabis and pharmaceutical products.
Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.
Riskit
ZeroStack faces a combination of digital-asset, regulatory, and operating-business risks. The 0G treasury strategy exposes results to token price volatility, custody and cybersecurity risk, while the pharmaceutical and cannabis businesses depend on licensing, cross-border compliance, and product-specific regulatory approvals. The company also carries early-stage execution risk because it operates multiple business lines across different legal regimes.
- 0G token volatilityVaikutus: KorkeaTodennäköisyys: Korkea
The company holds 0G as a strategic asset, so fair value changes can materially affect results.
Kohdistuu: Treasury holdings and listed securities valuation
- Custody and private-key lossVaikutus: KorkeaTodennäköisyys: Kohtalainen
Digital assets require secure custody; loss or compromise could permanently reduce holdings.
Kohdistuu: 0G treasury strategy
- Cannabis regulatory changeVaikutus: Korkea
Product legality, labeling, and distribution rules vary by jurisdiction and can restrict sales.
Kohdistuu - Cybersecurity and operational integrationVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Acquisitions and digital-asset operations increase attack surface and integration complexity.
Kohdistuu - Pharmaceutical compliance and licensingVaikutus: KeskitasoTodennäköisyys: Matala
Wholesale distribution depends on permits, import/export approvals, and local compliance.
Kohdistuu: Phatebo and international distribution
Kirjanpito
Harkinnanvaraiset erätSales are recognized when performance obligations are satisfied, with deductions for discounts and returns.
Vaikutus: Affects reported revenue timing and net sales
Cannabis accessory products include a six-month warranty and estimated claims must be accrued.
Vaikutus: Affects cost of sales and liabilities
Pharmaceutical, hemp, and accessory inventories may require write-downs if demand or compliance changes.
Vaikutus: Affects gross margin and working capital
0G holdings are marked through earnings under fair-value accounting for digital assets.
Vaikutus: Can create large non-operating gains or losses
Operating leases and debt commitments affect balance-sheet leverage and cash requirements.
Vaikutus: Affects liquidity and fixed-charge burden
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Verano Holdings Corp.
VRNO · Agricultural Production-Crops
Aurora Cannabis Inc
ACB · Medicinal Chemicals & Botanical Products
Trulieve Cannabis Corp.
TRLV · Medicinal Chemicals & Botanical Products
Canton Strategic Holdings, Inc.
CNTN · Finance Services
Cannapharmarx, Inc.
CPMD · Pharmaceutical Preparations
IM Cannabis Corp.
IMCC · Medicinal Chemicals & Botanical Products
Päivitetty: 24.9.2026